ADIPOQ Kit ELISA

N° du produit ABIN2745430

Le kit ELISA ADIPOQ (ABIN2745430) Souris est un kit ELISA Colorimetric conçu pour quantifier Souris ADIPOQ.

Aperçu rapide pour ADIPOQ Kit ELISA (ABIN2745430)

Antigène: ADIPOQ (Adiponectin (ADIPOQ))

Reactivité: Souris

Méthode de détection: Colorimetric

Type de méthode: Sandwich ELISA

Gamme de detection: 0.125-8 ng/mL

Application: ELISA

Type d'échantillon: Cell Culture Supernatant, Plasma, Serum

Détail du produit ADIPOQ Kit ELISA

Seuil minimal de détection: 0.125 ng/mL

Analytical Method: Quantitative

Specificité: Detects mouse adiponectin.

Réactivité croisée: Souris

Aucune reactivité croisée: Humain, Rat (Rattus)

Réactivité croisée (Details): Does not cross-react with human adiponectin, rat adiponectin, mouse resistin, mouse RELM-beta or mouse leptin.

Sensibilité: 50 pg/mL

Attributs du produit: Adiponectin (mouse) ELISA Kit

Information d'application

Plaque: Pre-coated

Restrictions: For Research Use only

Stockage

Stock: 4 °C

Stockage commentaire: Short Term Storage: +4°C
Long Term Storage: +4°C
12 months after the day of manufacturing. See expiry date on ELISA Kit box.

Détail du antigène

Antigène: ADIPOQ (Adiponectin (ADIPOQ))

Autre désignation: Adiponectin

Sujet: Adiponectin [ACRP30, AdipoQ] is a promising biomarker of insulin resistance and type 2 diabetes mellitus (T2DM) but also as a potential target for management of the metabolic syndrome. It is a very robust marker that is not prone to degradation or acute inflammatory challenges, is present in relatively high concentrations in the peripheral circulation, and can be collected by a variety of methods. The benefits of using adiponectin assays in clinical settings include, (a) prediction of risk of diabetes and metabolic status and (b) providing a tool to monitor metabolic improvements. Adiponectin exerts anti-atherogenic and anti-inflammatory properties and may be important as a biomarker for obesity-related cardiovascular disease (CVD). New findings showed urinary adiponectin excretion as an independent new biomarker of microvascular and macrovascular damage in T2DM and suggested it as a very promising tool for early cardiovascular disease risk assessment. Adiponectin serum level was also described as a good biomarker of colorectal adenoma, this being related to the positive correlation between obesity and increased risk of cancer at various sites (colorectal, breast, prostate and endometrium).

UniProt: Q60994